News

Press Releases, Publications, and Media Coverage

  • Awarded SBIR Phase 2 Grant

    Fyodor, a Baltimore-based biotechnology company, announced today that the US National Science Foundation (NSF) has awarded the company a Small Business Innovation Research (SBIR) Phase 2 grant. The $729,000 funding will help accelerate Fyodor’s effort to develop and validate a noninvasive multi-disease urine-based diagnostic test for Acute Febrile Illness (AFI), enabling the differential clinical diagnosis of […]

  • Baltimore Sun May 2013

    Hundreds of thousands of people die of malaria every year, most of them in Africa. Dr. Eddy C. Agbo wants people to get diagnosed quickly and easily — right in their homes — so they can seek treatment. The barrier to quick and easy diagnoses is that all available tests require blood. His Baltimore company […]

  • Awarded Phase 2 SBIR Grant

    Fyodor Biotechnologies Inc., a Baltimore-based diagnostic and biopharmaceutical company, announced today that the National Science Foundation has awarded the company a Small Business Innovation Research (SBIR) Phase 2 grant. The $476,000 funding will support Fyodor’s effort to develop and validate a broad-based non-invasive, single-step Urine Malaria Test (UMT Broad) for the clinical diagnosis of both […]

  • Video: SNNLive Interview

    SNNLive spoke with Anne Derrick VP, Business Development & Operations of Fyodor Biotechnologies, Inc. at the University of Maryland BioPark in Baltimore, MD.  Watch the video below.

  • Awarded a Phase 1 SBIR Grant

    Fyodor Biotechnologies, a Baltimore-based diagnostic and biopharmaceutical company, announced today that the National Science Foundation has awarded the company a Small Business Innovation Research (SBIR) Phase I grant. With the $150,000 funding, Fyodor plans to develop a novel recombinant antibody to be used in a urine-based test for the point-of-need detection of Leptospirosis. Leptospirosis is […]

  • Expansions within UMD BioPark

    Fyodor Biotechnologies Inc. announced today that it has expanded its office and laboratory space at the University of Maryland BioPark in Baltimore, moving from the BioPark’s BioInnovation Center (BIC) at 801 West Baltimore Street to the expanded BioInnovation Center across the street at 800 West Baltimore Street. The move is prompted by Fyodor’s advancing research […]

  • Awarded SBIR Phase 1 Grant

    Fyodor Biotechnologies, a Baltimore-based diagnostic and biopharmaceutical company, announced today that the National Science Foundation has awarded the company a Small Business Innovation Research (SBIR) Phase I grant. With the $150,000 funding, Fyodor plans to further progress the development of its innovative Urine Malaria Test (UMT) technology. “We are pleased to receive this award from the […]

  • CEO speaks at Africa Business Conference

    Fyodor Biotechnologies’ Chairman and CEO, Dr Eddy Agbo, was invited to participate in a panel at the 13th Annual Africa Business Conference sponsored by the Africa Business Club at the Harvard Business School February 18-20, 2011. The panel entitled “Africa’s Pharmaceutical Dilemma: The Opportunity for Private Entrepreneurs” provided a forum for interactive discussion on potential […]

  • Receive Biotechnology Commercialization Award

    Governor Martin O’Malley announced today that State grants are available in Fiscal Year 2011 through the Maryland Biotechnology Center to assist in commercializing promising research, encouraging bio companies to collaborate with academic institutions and expanding biotechnology resources. The Governor also announced that seven Maryland bio companies and universities received $1.3 million in FY 2010 grants, […]